FDA Regulatory Requirements for Clinical Investigators and Case Examples (9of14) REdI 2018

CDER’s Faranak Jamali notes that clinical investigators are among the most commonly inspected entities in CDER-regulated studies. Jamali provides discusses clinical investigator’s responsibilities and potential inspectional findings during the conduct of the clinical investigations.
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Phone: [phone] I [phone]